Skip to main content
  • AACR Publications
    • Blood Cancer Discovery
    • Cancer Discovery
    • Cancer Epidemiology, Biomarkers & Prevention
    • Cancer Immunology Research
    • Cancer Prevention Research
    • Cancer Research
    • Clinical Cancer Research
    • Molecular Cancer Research
    • Molecular Cancer Therapeutics

  • Register
  • Log in
  • Log out
  • My Cart
Advertisement

Main menu

  • Home
  • About
    • The Journal
    • AACR Journals
    • Subscriptions
    • Permissions and Reprints
    • Reviewing
  • Articles
    • OnlineFirst
    • Current Issue
    • Past Issues
    • Meeting Abstracts
    • Collections
      • Focus on Computer Resources
      • Highly Cited Collection
      • Editors' Picks
  • For Authors
    • Information for Authors
    • Author Services
    • Early Career Award
    • Best of: Author Profiles
    • Submit
  • Alerts
    • Table of Contents
    • OnlineFirst
    • Editors' Picks
    • Citations
    • Author/Keyword
  • News
    • Cancer Discovery News
  • AACR Publications
    • Blood Cancer Discovery
    • Cancer Discovery
    • Cancer Epidemiology, Biomarkers & Prevention
    • Cancer Immunology Research
    • Cancer Prevention Research
    • Cancer Research
    • Clinical Cancer Research
    • Molecular Cancer Research
    • Molecular Cancer Therapeutics

User menu

  • Register
  • Log in
  • Log out
  • My Cart

Search

  • Advanced search
Cancer Research
Cancer Research

Advanced Search

  • Home
  • About
    • The Journal
    • AACR Journals
    • Subscriptions
    • Permissions and Reprints
    • Reviewing
  • Articles
    • OnlineFirst
    • Current Issue
    • Past Issues
    • Meeting Abstracts
    • Collections
      • Focus on Computer Resources
      • Highly Cited Collection
      • Editors' Picks
  • For Authors
    • Information for Authors
    • Author Services
    • Early Career Award
    • Best of: Author Profiles
    • Submit
  • Alerts
    • Table of Contents
    • OnlineFirst
    • Editors' Picks
    • Citations
    • Author/Keyword
  • News
    • Cancer Discovery News
Articles

Multiple Neurotransmitter Synthesis by Human Neuroblastoma Cell Lines and Clones

June L. Biedler, Suzanne Roffler-Tarlov, Melitta Schachner and Lewis S. Freedman
June L. Biedler
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Suzanne Roffler-Tarlov
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Melitta Schachner
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Lewis S. Freedman
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
DOI:  Published November 1978
  • Article
  • Info & Metrics
  • PDF
Loading

Abstract

Continuously cultured human neuroblastoma cell lines SK-N-SH, SK-N-BE(1), SK-N-BE(2), and SK-N-MC, as well as several clonally derived sublines, were assessed for their neurotransmitter characteristics. Two different methods were used: measurement of cholinergic and adrenergic enzyme activities and detection of neurotransmitters synthesized from radioactive precursors. Dopamine-β-hydroxylase (EC 1.14.2.1), choline acetyltransferase (EC 2.3.1.6), acetylcholinesterase (EC 3.1.1.7), and butyrylcholinesterase (EC 3.1.1.8) levels were compared to those of various normal and neuronal cell controls. The capacity of neuroblastoma lines and clones to convert radioactive tyrosine, choline, and glutamate to transmitter products was determined. SK-N-SH, SK-N-BE(1), and SK-N-BE(2) cells had moderately high levels of dopamine-β-hydroxylase activity. Whereas neuroblast-like clones of SK-N-SH had similar levels of this enzyme, epithelial-like clones had no detectable activity. SK-N-BE(2) cells showed the greatest capacity to convert tyrosine to dopamine. Although the SK-N-SH line itself was not tested, both neuroblast and epithelial-like clones, shown by karyotype analysis to have a common cell precursor, converted tyrosine to dopamine. In contrast, the SK-N-MC line and its clones appeared devoid of adrenergic properties. All cells tested except human fibroblast-like cells of normal origin were able to convert radioactive choline to acetylcholine. While all the cell lines had measurable choline acetyltransferase activity, levels were substantially higher (at least 4- to 12-fold) for SK-N-MC cells and its clonally derived subline MC-IXC. All cells tested converted glutamate to γ-aminobutyric acid. Results indicate that these human neuroblastoma cell lines have predominating neurotransmitter characteristics that are sometimes, but not always, expressed in clones derived from them. Since the SK-N-BE(1) and SK-N-BE(2) lines were isolated 5 months apart from the same patient and have similar activity levels of dopamine-β-hydroxylase, these characteristics may be stable and representative of the tumor cells in vivo. Furthermore, results obtained by the two different methodological approaches suggest that, whereas SK-N-MC cells show cholinergic and not adrenergic traits, SK-N-SH and possibly SK-N-BE(2) may be multipotential with regard to neuronal enzyme expression.

Footnotes

  • ↵1 Recipient of NIH Grants CA-08748 and CA-18856. To whom requests for reprints should be addressed.

  • ↵2 Recipient of NIH Grants NS-09704 and NS-12200.

  • Received February 16, 1978.
  • Accepted August 18, 1978.
  • ©1978 American Association for Cancer Research.
PreviousNext
Back to top
November 1978
Volume 38, Issue 11 Part 1
  • Table of Contents
  • Table of Contents (PDF)
  • Back Matter (PDF)
  • Editorial Board (PDF)
  • Front Matter (PDF)

Sign up for alerts

Open full page PDF
Article Alerts
Sign In to Email Alerts with your Email Address
Email Article

Thank you for sharing this Cancer Research article.

NOTE: We request your email address only to inform the recipient that it was you who recommended this article, and that it is not junk mail. We do not retain these email addresses.

Enter multiple addresses on separate lines or separate them with commas.
Multiple Neurotransmitter Synthesis by Human Neuroblastoma Cell Lines and Clones
(Your Name) has forwarded a page to you from Cancer Research
(Your Name) thought you would be interested in this article in Cancer Research.
Citation Tools
Multiple Neurotransmitter Synthesis by Human Neuroblastoma Cell Lines and Clones
June L. Biedler, Suzanne Roffler-Tarlov, Melitta Schachner and Lewis S. Freedman
Cancer Res November 1 1978 (38) (11 Part 1) 3751-3757;

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
Share
Multiple Neurotransmitter Synthesis by Human Neuroblastoma Cell Lines and Clones
June L. Biedler, Suzanne Roffler-Tarlov, Melitta Schachner and Lewis S. Freedman
Cancer Res November 1 1978 (38) (11 Part 1) 3751-3757;
del.icio.us logo Digg logo Reddit logo Twitter logo CiteULike logo Facebook logo Google logo Mendeley logo
  • Tweet Widget
  • Facebook Like
  • Google Plus One

Jump to section

  • Article
  • Info & Metrics
  • PDF
Advertisement

Related Articles

Cited By...

More in this TOC Section

  • Laureate Citations
  • Conference Participants
  • The Partial Homeodomain of the Transcription Factor Pax-5 (BSAP) Is an Interaction Motif for the Retinoblastoma and TATA-binding Proteins
Show more Articles
  • Home
  • Alerts
  • Feedback
  • Privacy Policy
Facebook  Twitter  LinkedIn  YouTube  RSS

Articles

  • Online First
  • Current Issue
  • Past Issues
  • Meeting Abstracts

Info for

  • Authors
  • Subscribers
  • Advertisers
  • Librarians
  • Reviewers

About Cancer Research

  • About the Journal
  • Editorial Board
  • Permissions
  • Submit a Manuscript
AACR logo

Copyright © 2019 by the American Association for Cancer Research.

Cancer Research Online ISSN: 1538-7445
Cancer Research Print ISSN: 0008-5472
Journal of Cancer Research ISSN: 0099-7013
American Journal of Cancer ISSN: 0099-7374

Advertisement